Trials / Completed
CompletedNCT00800046
A Study of Percutaneous Repair of Functional Mitral Regurgitation Using the Ancora Heart, Inc. AccuCinch® Ventricular Repair System - The CINCH-2 Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Ancora Heart, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Prospective single-arm study of the AccuCinch® Ventriculoplasty System in the treatment of mitral valve regurgitation through subvalvular mitral repair. Purpose: To demonstrate the safety, feasibility and potential efficacy of using the AccuCinch® Ventriculoplasty System to reduce mitral valve regurgitation through subvalvular mitral repair.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AccuCinch® Ventriculoplasty System | Mitral valve repair due to functional disease |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2020-11-01
- Completion
- 2021-01-01
- First posted
- 2008-12-01
- Last updated
- 2021-07-29
Locations
8 sites across 3 countries: Austria, Germany, Lithuania
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT00800046. Inclusion in this directory is not an endorsement.